Literature DB >> 23054193

Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells.

Yinan Wang1, XiaoYan Yang, Sadako Yamagata, Tatsuya Yamagata, Toshinori Sato.   

Abstract

To know the involvement of glycosaminoglycans (GAGs) in the metastasis of mouse FBJ osteosarcoma cells, N(α)-lauroyl-O-(β-D-xylopyranosyl)-L-serinamide (Xyl-Ser-C12), which initiates elongation of GAG chains using the glycan biosynthesis system in cells, was administered to FBJ cells with different metastatic capacities. Production of glycosylated products derived from Xyl-Ser-C12, especially heparan sulfate (HS) GAG-type oligosaccharides such as GalNAc-GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-Ser-C12, was indicated in poorly metastatic FBJ-S1 cells more than in highly metastatic FBJ-LL cells by LC-MS. The results of RT-PCR revealed that HS synthases, Ext1 and Ext2, were expressed in FBJ-S1 cells more than in FBJ-LL cells. Furthermore, siRNA against Ext1 suppressed the expression of HS and enhanced the motility of FBJ-S1 cells. In addition, the expression of heparanase (HPSE) was enhanced in Ext-1-knockdown FBJ-S1 cells, and responsible for the increase in cell motility caused by the down-regulation of Ext1 expression. Our data provide the first evidence that Ext1 regulates the expression of HPSE and also indicated that levels of Ext1 and HPSE influenced the motility of FBJ cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054193     DOI: 10.1007/s11010-012-1475-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 2.  Glycan changes: cancer metastasis and anti-cancer vaccines.

Authors:  Min Li; Lujun Song; Xinyu Qin
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

3.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 4.  Heparan sulfate proteoglycans in invasion and metastasis.

Authors:  R D Sanderson
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

5.  Unraveling the specificity of heparanase utilizing synthetic substrates.

Authors:  Sherket B Peterson; Jian Liu
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

Review 6.  Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

Authors:  Neta Ilan; Michael Elkin; Israel Vlodavsky
Journal:  Int J Biochem Cell Biol       Date:  2006-07-06       Impact factor: 5.085

7.  Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.

Authors:  Tatsuya Ogishima; Hiroaki Shiina; Julia E Breault; Laura Tabatabai; William W Bassett; Hideki Enokida; Long-Cheng Li; Toshifumi Kawakami; Shinji Urakami; Leopoldo A Ribeiro-Filho; Masaharu Terashima; Makoto Fujime; Mikio Igawa; Rajvir Dahiya
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

8.  Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses.

Authors:  W H Raskind; E U Conrad; M Matsushita; E M Wijsman; D E Wells; N Chapman; L J Sandell; M Wagner; J Houck
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

9.  Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members.

Authors:  Tomomi Izumikawa; Toshiyasu Koike; Shoko Shiozawa; Kazuyuki Sugahara; Jun-ichi Tamura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2008-03-03       Impact factor: 5.157

Review 10.  Synthesis and sorting of proteoglycans.

Authors:  K Prydz; K T Dalen
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

View more
  7 in total

Review 1.  The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.

Authors:  Maurizio Pacifici
Journal:  Matrix Biol       Date:  2017-12-24       Impact factor: 11.583

2.  Heparanase stimulates chondrogenesis and is up-regulated in human ectopic cartilage: a mechanism possibly involved in hereditary multiple exostoses.

Authors:  Julianne Huegel; Motomi Enomoto-Iwamoto; Federica Sgariglia; Eiki Koyama; Maurizio Pacifici
Journal:  Am J Pathol       Date:  2015-04-08       Impact factor: 4.307

Review 3.  Genetics of breast cancer bone metastasis: a sequential multistep pattern.

Authors:  Hassan Fazilaty; Parvin Mehdipour
Journal:  Clin Exp Metastasis       Date:  2014-02-04       Impact factor: 5.150

4.  Hereditary multiple exostoses: are there new plausible treatment strategies?

Authors:  Maurizio Pacifici
Journal:  Expert Opin Orphan Drugs       Date:  2018-06-07       Impact factor: 0.694

5.  Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Authors:  Oualid Haddad; Erwan Guyot; Nicolas Marinval; Fabien Chevalier; Loïc Maillard; Latifa Gadi; Christelle Laguillier-Morizot; Olivier Oudar; Angela Sutton; Nathalie Charnaux; Hanna Hlawaty
Journal:  Mar Drugs       Date:  2015-10-28       Impact factor: 5.118

6.  Saccharide Primers Comprising Xylosyl-Serine Primed Phosphorylated Oligosaccharides Act as Intermediates in Glycosaminoglycan Biosynthesis.

Authors:  Yuya Otsuka; Toshinori Sato
Journal:  ACS Omega       Date:  2017-07-03

7.  Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.

Authors:  Ling Ren; Arnulfo Mendoza; Jack Zhu; Joseph W Briggs; Charles Halsey; Ellen S Hong; Sandra S Burkett; James Morrow; Michael M Lizardo; Tanasa Osborne; Samuel Q Li; Hue H Luu; Paul Meltzer; Chand Khanna
Journal:  Oncotarget       Date:  2015-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.